Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer
- 1 August 2004
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 45, S145-S150
- https://doi.org/10.1016/j.lungcan.2004.07.979
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Multidisciplinary Management of Lung CancerNew England Journal of Medicine, 2004
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Adjuvant chemotherapy after complete resection for early stage NSCLCLung Cancer, 2003
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1JNCI Journal of the National Cancer Institute, 2001
- Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion KinaseMolecular and Cellular Biology, 2001
- The Hallmarks of CancerCell, 2000
- c‐erbB‐2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cellsThe FASEB Journal, 1999
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995